3 No-Brainer Stocks to Buy on the Latest Sell-Off

The article is a bullish stock-picking piece arguing that recent market sell-offs have created attractive entry points in three companies: ExxonMobil, Nvidia, and Vertex Pharmaceuticals. It highlights ExxonMobil’s strong earnings and cash-flow growth, cheap valuation, and 3.75% dividend yield amid weakness tied to lower oil prices. Nvidia is presented as a long-term leader despite a 13% pullback, with Blackwell GPU demand described as very strong and data-center spending shifting toward accelerated computing. Vertex Pharmaceuticals sold off after disappointing phase 2 pain-drug data, but the article says the drug still met its primary endpoint, remains on track for phase 3, and Vertex also received FDA approvals for Trikafta label expansion and Alyftrek. Overall, the market impact is framed as a constructive “buy the dip” message for fundamentally strong large-cap names.